ankara šocuk endokrin ankara šocuk endokrinoloji doktorlarř
D─░YABET HASTALI─×ININ EKONOM─░K Y├ťK├ť - THE ECONOMIC BURDEN of DIABETES | ├ľcal | Eski┼čehir T├╝rk D├╝nyas─▒ Uygulama ve Ara┼čt─▒rma Merkezi Halk Sa─čl─▒─č─▒ Dergisi (ISSN:2564-6311)

D─░YABET HASTALI─×ININ EKONOM─░K Y├ťK├ť - THE ECONOMIC BURDEN of DIABETES

Ece Elif ├ľcal, Muhammed Fatih ├ľns├╝z

├ľz


Diyabet, ins├╝lin ├╝retimi ya da kullan─▒m─▒nda meydana gelen patolojilerden kaynaklanan ciddi kronik bir hastal─▒kt─▒r. Ge├žti─čimiz birka├ž dekadda diyabet prevelans─▒ artarak, 21.y├╝zy─▒l─▒n en b├╝y├╝k k├╝resel salg─▒nlar─▒ndan biri haline gelmi┼čtir. Diyabet ve diyabete ba─čl─▒ olu┼čan komplikasyonlar─▒n yol a├žt─▒─č─▒ sorunlarla ya┼čayan insan say─▒s─▒ her ge├žen y─▒l giderek artmakta ve b├╝y├╝k bir ekonomik y├╝k olu┼čturmaktad─▒r. Bu y├╝k├╝n maliyetinin hesaplanmas─▒nda direkt ve indirekt olmak ├╝zere 2 bile┼čen vard─▒r. D├╝nya ├žap─▒nda diyabetin y─▒ll─▒k direkt maliyeti 825 milyar dolard─▒r.

Diyabetli pop├╝lasyonun %75.4ÔÇÖ├╝ d├╝┼č├╝k ve orta gelirli ├╝lkelerde ya┼čamakta ancak diyabete y├Ânelik k├╝resel sa─čl─▒k harcamalar─▒n─▒n sadece %19ÔÇÖu bu ├╝lkelere harcanmaktad─▒r. D├╝nya Sa─čl─▒k ├ľrg├╝t├╝ÔÇÖn├╝n 2016 diyabet raporuna g├Âre, toplam k├╝resel diyabet harcamalar─▒ndaki art─▒┼č─▒n devam etmesi beklenmektedir. Risk fakt├Ârleri ve sonradan ortaya ├ž─▒kan hastal─▒klar─▒n erken d├Ânemde ba┼člayabilece─či g├Âz ├Ân├╝ne al─▒nd─▒─č─▒nda, prematur ├Âl├╝mlerin┬á├Ânlenmesi, ya┼čam kalitesinin iyile┼čtirilmesi ve sa─čl─▒k sistemi ├╝zerindeki ekonomik y├╝k├╝n azalt─▒lmas─▒ i├žin hastal─▒k ├Ânleme ve sa─čl─▒─č─▒ geli┼čtirme ├žal─▒┼čmalar─▒n─▒n yap─▒lmas─▒ bir gerekliliktir.

Anahtar Kelimeler: diyabet, maliyet, sa─čl─▒k harcamas─▒

THE ECONOMIC BURDEN of DIABETES

Diabetes is a serious chronic disease caused by pathologies of production or use of insulin. In the past few decades, the prevelance of diabetes has been increased and became one of the greatest global epidemics of the 21st century. The number of people living with the problems caused by diabetes and diabetes-related complications are increasing every year and occur a great economic burden. In calculation of the cost of this burden include two components named direct and indirect. The worldwide direct cost of diabetes is 825 billion dollars.

Although 75,4% of the population who have diabetes live in low and middle income countries and only 19% of the worldwide health expenditures for these countries. According to report of the World Health Organization 2016 about diabetes, it is expected that the health expenditures for diabetes will continue by increasing. Considering the risk factors and subsequent disease may begin at early stage, it is essential to prevent disease and improve health promotion research for preventing of premature deaths, upgrading of the quality of life and reducing the economic burden on the health care system.

Keywords: diabetes, cost, health expenditure


Tam Metin:

ARTICLE 3

Referanslar


WHO., Global action plan for the prevention and control of noncommunicable diseases 2013-2020. 2013.

Alwan, A., Global status report on noncommunicable diseases 2010. 2011: World Health Organization.

Zimmet, P., K. Alberti, and J. Shaw, Global and societal implications of the diabetes epidemic. Nature, 2001. 414(6865): p. 782-787.

Boyle, J.P., et al., Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population health metrics, 2010. 8(1): p. 29.

World Health Organization. (2016). Global report on diabetes.

T├╝rkiye Diyabet Program─▒ 2015-2020, Sa─čl─▒k Bakanl─▒─č─▒ Yay─▒nlar─▒, Ankara. 2014:47ÔÇô49.

http://www.diabetes.org/diabetes-basics/type-1/?loc=db-slabnav (Eri┼čim tarihi: 10.09.2017).

http://www.diabetes.org/diabetes-basics/type-2/facts-about-type 2.html?loc=db-slabnav (Eri┼čim tarihi: 10.09.2017).

Association, A.D., Diagnosis and classification of diabetes mellitus. Diabetes care, 2014. 37(Supplement 1): p. S81-S90.

Association, A.D., National diabetes statistics report, 2014. Estimates of diabetes and its burden in the epidemiologic estimation methods. Natl Diabetes Stat Rep, 2014: p. 2009-2012.

Shaw, J.E., R.A. Sicree, and P.Z. Zimmet, Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice, 2010. 87(1): p. 4-14.

http://www.who.int/features/factfiles/diabetes/en/ (Eri┼čim tarihi: 15.09.2017).

IDF, I. (2015). IDF diabetes atlas seventh edition.

Satman, I., et al., Population-based study of diabetes and risk characteristics in Turkey. Diabetes care, 2002. 25(9): p. 1551-1556.

Satman, I., et al., Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. European journal of epidemiology, 2013. 28(2): p. 169-180.

T├ť─░K, T├╝rkiye Sa─čl─▒k Ara┼čt─▒rmas─▒, 2012.

Rapor, H.Y.F., U.H. Y├╝k├╝, and M.E. Projesi, TC Sa─čl─▒k Bakanl─▒─č─▒ Refik Saydam H─▒fz─▒ss─▒hha Merkezi Ba┼čkanl─▒─č─▒ H─▒fz─▒ss─▒hha Mektebi M├╝d├╝rl├╝─č├╝, Ba┼čkent ├ťniversitesi. RSHMB H─▒fz─▒ss─▒hha Mektebi M├╝d├╝rl├╝─č├╝, 2004.

Morsanutto, A., et al., Maj├Âr komplikasyonlar─▒n diyabetin toplam y─▒ll─▒k t─▒bbi maliyeti ├╝zerine etkisi vard─▒r. Journal of Diabetes and its Complition, 2006.2(3): p. 152-159.

Association, A.D., Economic costs of diabetes in the US in 2012. Diabetes care, 2013. 36(4): p. 1033-1046.

Collaboration, N.R.F., Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4┬Ě 4 million

participants. The Lancet, 2016. 387(10027): p. 1513-1530.

www.turkstat.gov.tr/IcerikGetir.do?istab_id=5 T├ť─░K, ─░statistiklerle T├╝rkiye, 2014(Eri┼čim Tarihi:18.09.2017).

Aguiree, F., et al., IDF diabetes atlas. 2013.

Nichols, G.A. and J.B. Brown, The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes

Care, 2002. 25(3): p. 482-486.

Hoerger, T.J., et al., Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Annals of Internal Medicine, 2004. 140(9): p. 689-

Slawson, D.L., N. Fitzgerald, and K.T. Morgan, Position of the Academy of Nutrition and Dietetics: the role of nutrition in health promotion and chronic disease prevention. Journal of the Academy of Nutrition and Dietetics, 2013. 113(7): p. 972-979.

Gillies, C.L., et al., Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. Bmj, 2008. 336(7654): p.1180-1185.

Group, D.P.P.R., Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes care, 2003.26(9): p. 2518-2523.

Wolf, A.M., et al., Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN). Journal of the American Dietetic Association, 2007. 107(8): p. 1365-1373.


Refback'ler

  • ┼×u halde refbacks yoktur.